BIOCARE COPENHAGEN

Copenhagen, Denmark Founded: 2012 • Age: 14 yrs Acquired By DSM
Probiotics are developed for treating gastrointestinal disorders, infections, and immunity.
Request Access

About BIOCARE COPENHAGEN

BIOCARE COPENHAGEN is a company based in Copenhagen (Denmark) founded in 2012 was acquired by DSM in December 2017.. BIOCARE COPENHAGEN operates in a competitive market with competitors including Novozymes, Seed, Seres Therapeutics, MaaT Pharma and Genome & Company, among others.

  • Headquarter Copenhagen, Denmark
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    DSM

    (Dec 22, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BIOCARE COPENHAGEN

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BIOCARE COPENHAGEN

BIOCARE COPENHAGEN has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include dsm-firmenich. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Health, nutrition, and bioscience solutions are delivered worldwide.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BIOCARE COPENHAGEN

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BIOCARE COPENHAGEN

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biocare Copenhagen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BIOCARE COPENHAGEN

BIOCARE COPENHAGEN operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Seed, Seres Therapeutics, MaaT Pharma and Genome & Company, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biosolutions and enzymes are developed for biotechnology applications across industries.
domain founded_year HQ Location
Synbiotics are developed for simulating the gut microbiome.
domain founded_year HQ Location
Microbiome therapeutics are developed to address diverse diseases.
domain founded_year HQ Location
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
domain founded_year HQ Location
Microbiome-based immuno-oncology drugs are developed using proprietary technology.
domain founded_year HQ Location
Drugs from gut bacteria are developed for multiple diseases.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biocare Copenhagen

Frequently Asked Questions about BIOCARE COPENHAGEN

When was BIOCARE COPENHAGEN founded?

BIOCARE COPENHAGEN was founded in 2012.

Where is BIOCARE COPENHAGEN located?

BIOCARE COPENHAGEN is headquartered in Copenhagen, Denmark.

What does BIOCARE COPENHAGEN do?

BioCare Copenhagen was established in 2012 in Copenhagen, Denmark, within the biotechnology sector. Probiotics are created for both supplemental use and therapeutic purposes targeting diseases. Development efforts encompass lactic acid bacteria, yeast cells, microbial lysates, and tyndalized bacteria. Operations center on addressing gastrointestinal disorders, infections, and immune system support through these microbial solutions.

Who are the top competitors of BIOCARE COPENHAGEN?

BIOCARE COPENHAGEN's top competitors include Novozymes, Seres Therapeutics and Seed.

Who are BIOCARE COPENHAGEN's investors?

BIOCARE COPENHAGEN has 1 investor. Key investors include dsm-firmenich.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available